Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2004101585) MACROLIDES SUBSTITUDED AT THE 4'-POSITION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2004/101585 International Application No.: PCT/EP2004/005081
Publication Date: 25.11.2004 International Filing Date: 11.05.2004
IPC:
C07H 17/08 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
04
Heterocyclic radicals containing only oxygen as ring hetero atoms
08
Hetero rings containing eight or more ring members, e.g. erythromycins
Applicants:
ALIHODZIC, Sulejman [HR/HR]; HR (UsOnly)
BERDIK, Andrea [HR/HR]; HR (UsOnly)
BERGE, John, Michael [GB/GB]; GB (UsOnly)
JARVEST, Richard, Lewis [GB/GB]; GB (UsOnly)
MUTAK, Stjepan [HR/HR]; HR (UsOnly)
GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN, GB (AllExceptUS)
PLIVA - ISTRAZIVACKI INSTITUT D.O.O. [HR/HR]; Prilaz baruna Filipovica 29 10000 Zagreb, HR (AllExceptUS)
Inventors:
ALIHODZIC, Sulejman; HR
BERDIK, Andrea; HR
BERGE, John, Michael; GB
JARVEST, Richard, Lewis; GB
MUTAK, Stjepan; HR
Agent:
GLADWIN, Amanda, Rachel; GlaxoSmithKline Corporate Intellectual Property (CN925.1) 980 Great West Road Brentford Middlesex TW8 9GS, GB
Priority Data:
0310984.013.05.2003GB
Title (EN) MACROLIDES SUBSTITUDED AT THE 4'-POSITION
(FR) MACROLIDES SUBSTITUES EN POSITION 4''
Abstract:
(EN) The present invention relates to 14- or 15-membered macrolides substituted at the 4' position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
(FR) La présente invention concerne des macrolides à 14 ou 15 éléments substitués en position 4'', représentés par la formule (I), ainsi que des dérivés pharmaceutiquement acceptables de ces composés et leurs procédés de préparation et d'utilisation dans le traitement et la prévention d'infections microbiennes systémiques ou locales chez l'homme ou l'animal.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)